// App-Quantinova.ai

P1126 : MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF A PIVOTAL PHASE II STUDY

Researchers

Presenter

  • Matthew Matasar

Principal Investigators

  • Laurie H. Sehn

  • Stephen J Schuster

  • Sarit Assouline

  • Pratyush Giri

  • John Kuruvilla

  • Miguel Canales

  • Sascha Dietrich

  • Keith Fay

  • Matthew Ku

  • Loretta J. Nastoupil

  • Michael C. Wei

  • Shen Yin

  • Iris To

  • David Turner

  • Huang Huang

  • Juliana Min

  • Elicia Penuel

  • L. Elizabeth Budde

Medical Centers

  • Hoffmann-La Roche Ltd,Mississauga, ON,Канада

  • Hospital Universitario La Paz, Madrid, Spain

  • MD Anderson Cancer Center ,Houston,Verenigde Staten

  • St Vincent's Hospital and Royal North Shore Hospital,Sydney,Australie

  • BC Cancer Centre for L

  • City of Hope,Duarte, CA,Estados Unidos

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

  • City of Hope, Duarte, United States

  • Roche Products Ltd,Welwyn Garden City,Royaume-uni

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • University Clinic Heidelberg, Heidelberg, Germany

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • Jewish General Hospital, Montreal, QC, Canada

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Hospital Universitario La Paz, Madrid, Spain

  • Roche Products Ltd,Welwyn Ga

  • Hospital Universitario La Paz, Madrid, Spain

  • MD Anderson Cancer Center ,Houston,Verenigde Staten

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Genentech Inc., San Francisco, United States

  • Jewish General Hospital,Montreal,Канада

  • Universitat Heidelberg,Heidelberg,Allemagne

  • Roche Products Ltd,Welwyn Garden City,Reino Unido

  • City of Hope, Duarte, CA

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Hospital Universitario La Paz,Madrid,Испания

  • Royal Adelaide Hospital, Adelaide, Australia

  • Universitat Heidelberg,Heidelberg,Allemagne

  • Universitat Heidelberg,Heidelberg,Allemagne

  • Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, MO

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Royal Adelaide Hospital, Adelaide, Australia

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • Siteman Cancer Center, Washingto

  • University of Heidelberg,Heidelberg,Германия

  • St Vincent's Hospital and Royal North Shore Hospi

  • City of Hope,Duarte,Vereinigte Staaten

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • Jewish General Hospital, Montreal, QC, Canada

  • Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • City of Hope,Duarte,Stati Uniti

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • MD Anderson Cancer Center,Houston, TX,Estados Unidos

  • MD Anderson Cancer Center,Houston, TX,Estados Unidos

  • Memorial Sloan Kettering Cancer Center,New York ,États-unis

  • Roche Products Ltd,Welwyn Garden City,Reino Unido

  • Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

  • Genentech, Inc.,South San Francisco,Verenigde Staten

  • Hospital Universitario La Paz, Madrid, Spain

  • St Vincent's Hospital and Royal North Shore Hospital,Sydney,Australie

  • Royal Adelaide Hospital, Adelaide, Australia

  • Genentech Inc.

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • Hospital Universitario La Paz, Madrid, Spain

  • Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, MO

  • University Clinic Heidelberg, Heidelberg, Germany

  • Royal Adelaide Hospital, Adelaide, Australia

  • Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

  • Genentech, Inc.,South San Francisco,Verenigde Staten

  • City of Hope,Duarte,États-unis

  • Roche Products Ltd,Welwyn Garden City,Verenigd Koninkrijk

  • Royal Adelaide Hospital,Adelaide,Австралия

  • MD Anderson Cancer Center,Houston, TX,Estados Unidos

  • Hospital Universitario La Paz, Madrid, Spain

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Jewish General Hospital, Montreal, QC, Canada

  • Royal Adelaide Hospital, Adelaide, Australia

  • City of Hope,Duarte,Vereinigte Staaten

  • 1.MD Anderson Cancer Center, Houston, TX

  • Roche Products Ltd,Welwyn Garden City,Verenigd Koninkrijk

  • BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Hospital Universitario La Paz, Madrid, Spain

  • St Vincent's Hospital and Royal North Shore Hospital,Sydney,Australie

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

Locations

  • United States

  • Canada

  • Australia

  • Uruguay

  • Spain

  • South Africa

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Cytokine release syndrome

  • Follicular lymphoma

  • Lymphomas

Biomarkers

  • Cytokine

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT02500407

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved